302957-95-5

Basic information

• Product Name: Carbamic acid, [5-[[(2,4-dichlorophenyl)amino]carbonyl]-4-methyl-2-thiazolyl]-, 1,1-dimethylethyl ester
• CAS NO: 302957-95-5
• Molecular Formula: C16H17Cl2N3O3S
• Molecular Weight: 402.301
• Mol File: 302957-95-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [5-[[(2,4-dichlorophenyl)amino]carbonyl]-4-methyl-2-thiazolyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [5-[[(2,4-dichlorophenyl)amino]carbonyl]-4-methyl-2-thiazolyl]-, 1,1-dimethylethyl ester(302957-95-5)
• EPA Substance Registry System: Carbamic acid, [5-[[(2,4-dichlorophenyl)amino]carbonyl]-4-methyl-2-thiazolyl]-, 1,1-dimethylethyl ester(302957-95-5)

Safety Data

• Hazardous Substances Data: 302957-95-5(Hazardous Substances Data)

Upstream product

• 554-00-7 2,4-Dichloroaniline 
• 302963-95-7 2-[[(tert-butyloxy)carbonyl]amino]-4-methyl-1,3-thiazole-5-carboxylic acid chloride 
• 24424-99-5 di-tert-butyl dicarbonate 
• 302963-94-6 2-[[(tert-butyloxy)carbonyl]amino]-4-methyl-1,3-thiazole-5-carboxylic acid 
• 244236-52-0 ethyl 2-[[(tert-butyloxy)carbonyl]amino]-4-methyl-1,3-thiazole-5-carboxylate 

Downstream Products

• 302957-96-6 2-amino-N-(2,4-dichlorophenyl)-4-methyl-5-thiazolecarboxamide, trifluoroacetate 

Relevant articles and documents

Synergistic methods and compositions for treating cancer

Combination therapies using IGF1R inhibitors in combination with additional kinase inhibitors are described for the synergistic treatment of cancer.

Cyclic protein tyrosine kinase inhibitors

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.